| Company | IgA | IgG | IgM | Rmarks |
| Aesku.Diagnostics | Cardiolipin-A | Cardiolipin-GM | Cardiolipin-GM |
Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I + cardiolipin Entity: Qualitative and quantitative |
| Aesku.Diagnostics | Cardiolipin-Check | Cardiolipin-Check | Cardiolipin-Check |
Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I + cardiolipin Entity: Qualitative and quantitative |
| AIDA | Cardiolipin Ig |
Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I + cardiolipin Entity: Qualitative and quantitative |
||
| Bio-Rad | Anti-Cardiolipin | Anti-Cardiolipin | Anti-Cardiolipin |
Method: EIA Assay principle: Two step Entity: Semi-quantitative |
| Bio-Rad | BioPlex 2200 APLS IgA | BioPlex 2200 APLS IgG | BioPlex 2200 APLS IgM | Method: Bioplex (beats) immuno assay
Assay principle: A two step simultaneous detection of two auto antibodies Coating: anti-Cardiolipin and anti-Beta-2 Glycoprotein I Entity: Quantitative |
| Cambridge Life Sciences | AUTOZYME ACL | AUTOZYME ACL | AUTOZYME ACL |
Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I cofactor+ cardiolipin. Entity: Quantitative |
| Dialab | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG/IgM | Anti-Cardiolipin IgG/IgM |
Method: EIA Assay principle: Two step Entity: Quantitative |
| Dialab | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen |
Method: EIA Assay principle: Two step Entity: Semi-Quantitative |
| Diamedix | Immunosimplicity anti-Cardiolipin IgA Test Kit | Immunosimplicity anti-Cardiolipin IgG/IgM Test Kit | Immunosimplicity anti-Cardiolipin IgG/IgM Test Kit |
Method: EIA Assay principle: Two step Entity: Semi-quantitative |
| Diamedix | Immunosimplicity anti-Cardiolipin Screen | Immunosimplicity anti-Cardiolipin Screen | Immunosimplicity anti-Cardiolipin Screen | Method: EIA
Assay principle: Two step Entity: Semi-quantitative |
| DiaSorin | LIAISON Cardiolipin IgG | LIAISON Cardiolipin IgM | Method: CLIA
Entity: Semi-quantitative |
|
| Euroimmun | cardiolipin (AMA M1) | cardiolipin (AMA M1) | cardiolipin (AMA M1) | Method: EIA
Assay principle: Two step |
| Generic | Cardiolipin antibodies – IgG,IgM | Cardiolipin antibodies – IgG,IgM |
Method: EIA Assay principle: Two step Coating: Bovin Cardiolipin, human ß2 GP I Entity: Quantitative |
|
| Generic | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen |
Method: EIA Assay principle: Two step Coating: Bovin Cardiolipin, human ß2 GP I Entity: Semi-quantitative |
| Hemagen-Virgo VIRGO Cardiolipin | Virgo, Cardiolipin ELISA Test System | Virgo, Cardiolipin ELISA Test System | Virgo, Cardiolipin ELISA Test System | Method: EIA
Assay principle: Two step Entity: Quantitative |
| Hyphen BioMed | ZYMUTEST™ ACA-APA, IgG,IgM | ZYMUTEST™ ACA-APA, IgG,IgM |
Method: EIA Assay principle: Two step Coating: Anionic phospholipids Entity: Quantitative |
|
| IBL | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG,IgM | Anti-Cardiolipin IgA IgG,IgM |
Method: EIA Assay principle: Two step Coating: Cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| IBL | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen |
Method: EIA Assay principle: Two step Coating: Cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Immunodiagnosticsystems | Cardiolipin IgG | Cardiolipin IgM |
Method: CLIA Entity: Quantitative |
|
| Immuno Concepts | RELISA Cardiolipin | RELISA Cardiolipin |
Method: EIA Assay principle: Two step Coating: Cardiolipin (from beef heart) Entity: Quantitative |
|
| Imtec | Cardiolipin-Antibodies Screen | Cardiolipin-Antibodies Screen | Cardiolipin-Antibodies Screen |
Method: EIA Assay principle: Two step Coating: Cardiolipin + purified human ß2-glycoprotein I Entity: Quantitative |
| Imtec | Cardiolipin-Antibodies Combi |
Cardiolipin-Antibodies Combi |
Method: EIA Assay principle: Two step Coating: Cardiolipin + purified human ß2-glycoprotein I Entity: Quantitative |
|
| Imtec | Cardiolipin-Antibodies IgA |
Cardiolipin-Antibodies IgG |
Cardiolipin-Antibodies IgM |
Method: EIA Assay principle: Two step Coating: Cardiolipin + purified human ß2-glycoprotein I Entity: Quantitative |
| Louisville APL Diagnostics | APL IgA ELISA Kit | APL IgG ELISA Kit | APL IgM ELISA Kit |
Method: EIA Assay principle: Two step Coating: Cardiolipin + bovine ß2-glycoprotein I Entity: Semi-quantitative |
| Orgentec | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG/IgM | Anti-Cardiolipin IgG/IgM |
Method: EIA Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Orgentec | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen |
Method: EIA Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Orgentec | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG | Anti-Cardiolipin IgM |
Method: EIA (Alegria) Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Orgentec | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen |
Method: EIA (Alegria) Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| REAADS | Anti-Cardiolipin (aCL) IgA | Anti-Cardiolipin (aCL) IgG | Anti-Cardiolipin (aCL) IgM |
Method: EIA Coating: Cardiolipin Assay principle: Two step Entity: Quantitative |
| REAADS | Anti-Cardiolipin (aCL) IgG/IgM | Anti-Cardiolipin (aCL) IgG/IgM |
Method: EIA Coating: Cardiolipin Assay principle: Two step Entity: Quantitative |
|
| Stago | Asserachrom APA | Asserachrom APA |
Method: EIA Assay principle: Two step Entity: Quantitative |
|
| Stago | Asserachrom APA Screen | Asserachrom APA Screen | Asserachrom APA Screen |
Method: EIA Assay principle: Two step Entity: Quantitative |
| SVAR | Cardiolipin antibodies – IgA | Cardiolipin antibodies – IgG and IgM | Cardiolipin antibodies – IgG and IgM |
Method: EIA Assay principle: Two step Entity: Semi-quantitative |
| Thermo Scientific | EliA Cardiolipin IgA Well | EliA Cardiolipin IgG Well | EliA Cardiolipin IgM Well |
Method: EIA Coating: Bovin cardiolipin + ß2-glycoprotein I Assay principle: Two step Entity: Quantitative |
| TheraTest | EL-aCL IgM, IgG, IgA | EL-aCL IgM, IgG, IgA | EL-aCL IgM, IgG, IgA |
Method: EIA Assay principle: Two step Coating: Cardiolipin Entity: Quantitative |
| Werfen | AcuStar Anti-Cardiolipin Controls IgG | AcuStar Anti-Cardiolipin Controls IgM |
Method: EIA (chemiluminescent) Assay principle: Two step Coating: Bovine cardiolipin + purified human ß2-glycoprotein I Entity: Semi-quantitative |
|
| Werfen | QUANTA Flash Cardiolipin IgA | QUANTA Flash Cardiolipin IgG | QUANTA Flash Cardiolipin IgM |
Method: CIA Entity: Semi-quantitative |
| Werfen | QUANTA Lite® ACA IgA III | QUANTA Lite® ACA IgG III | QUANTA Lite® ACA IgM III |
Method: EIA Assay principle: Two step Coating: Purified cardiolipin + bovine ß2-glycoprotein I Entity: Semi-quantitative |
| Zeus Scientific | Cardiolipin IgA Test System | Cardiolipin IgG Test System | Cardiolipin IgM Test System |
Method: EIA Assay principle: Two step Coating: Bovin heart cardiolipin Entity: Semi-quantitative |